Dr. Buchwald obtained his doctorate from the University of Florida. He has worked in multi-disciplinary fields related to drug design and development both in the academic and industrial settings.

Dr. Buchwald has published numerous articles in peer-reviewed journals focused on the physicochemical and metabolic aspects of drug design and drug action, as well as on computer-aided quantitative modeling.

Coming from the pharmaceutical industry, Dr. Buchwald is directing the DRI's efforts aimed at developing safer and more effective drugs for islet replacement therapies.